ÌÇÐÄÆƽâ°æ

Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2016

Region

Worldwide

Survey time period

2014

Age group

18 years and older

Supplementary notes

* Composed of total prevalent cases ≥18 years of age in the U.S., France, Germany, Italy, Spain, UK, Japan, and China.

Citation formats

Major pharma markets epidemiology of chronic hepatitis B 2014

Published by ÌÇÐÄÆƽâ°æ Research Department, Dec 12, 2016
This statistic shows the epidemiology of chronic hepatitis B in eight countries representing the major pharmaceutical markets worldwide in 2014. In these countries combined, the population number aged 18 years and older with chronic hepatitis B was **** million.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in RussiaGlobal pharmaceutical industryTop pharmaceutical drugsHealthcare in RussiaCoronavirus (COVID-19) in Russia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.